How to buy Genetron stock (GTH)

Genetron is a diagnostics & research business based in the US. Genetron shares (GTH) are listed on the NASDAQ and all prices are listed in US Dollars. Genetron employs 993 staff and has a trailing 12-month revenue of around $650.7 million.

Our top picks for where to buy Genetron stock

Buy Genetron stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Genetron stock price (NASDAQ: GTH)

Use our graph to track the performance of GTH stocks over time.

Genetron shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$3.66 - $4.05
50-day moving average more info button	$3.87
200-day moving average more info button	$3.33
Wall St. target price	$1.34
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.62

Is it a good time to buy Genetron stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genetron financials

Revenue TTM	$650.7 million
Gross profit TTM	$338 million
Return on assets TTM	-35.2%
Return on equity TTM	-92.2%
Profit margin	-124.24%
Book value	$17.90
Market Capitalization more info button	$127.3 million

TTM: trailing 12 months

Genetron share dividends

We're not expecting Genetron to pay a dividend over the next 12 months.

Have Genetron's shares ever split?

Genetron's shares were split on a 1:3 basis on 25 October 2023 . So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Genetron shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Genetron shares which in turn could have impacted Genetron's share price.

Genetron share price volatility

Over the last 12 months, Genetron's shares have ranged in value from as little as $3.66 up to $4.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genetron's is 0.498. This would suggest that Genetron's shares are less volatile than average (for this exchange).

Genetron overview

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China. .

Frequently asked questions

null
What percentage of Genetron is owned by insiders or institutions?
Currently 6.82% of Genetron shares are held by insiders and 12.505% by institutions. How many people work for Genetron?
Latest data suggests 993 work at Genetron. When does the fiscal year end for Genetron?
Genetron's fiscal year ends in December. Where is Genetron based?
Genetron's address is: Building 11, Beijing, China, 102206 What is Genetron's ISIN number?
Genetron's international securities identification number is: US37186H1005